The research report on “Global Biosurgery Market” covers the different market scenarios that have a direct impact on the growth of the market. The Global Biosurgery Market was valued at USD 12.2 billion in 2021 and is expected to reach USD 16.0 billion by 2026, expanding at a CAGR of 5.7% by the end of the forecast period. The study includes information on market factors such as the market dynamics, including drivers, restraints, challenges, threats, and the potential growth opportunities, market trends, development patterns, financial information (revenue), latest technologies, innovations, leading competitors, and regional analysis of the market. The market is expected to grow at a significate rate during the forecast period, owing to the demand from all corners of the globe.
In the first section, the report consists of the basic overview of the market, including product definitions, classifications, new product launches, key developments, and the industry chain structure of the overall market. Besides, the report covers intelligence of different segments such as the product type, technology, application, industry vertical, end-user, and geography. In the next section, the report focuses on the industry development policies, plans, production cost, value, volume, import/export, cost structures, supply and value chain analysis, manufacturing processes, and consumption figures. Furthermore, the report highlights the regional and segment-based aspects to access the untapped opportunities in the Global Biosurgery Market. The information is provided in the form of year-to-year evolution and basis point share, I term of CAGR and revenue.
Request a Sample Report: https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302
Prominent Players in Biosurgery Market are:
Johnson & Johnson (US), Baxter International Inc. (US), Medtronic Plc (Ireland), Becton, Dickinson & Co. (US), B. Braun Melsungen AG (Germany), Stryker Corp. (US), Integra Lifesciences Holdings Corp. (US), CSL Ltd. (Australia), Hemostasis LLC. (US), Pfizer Inc. (US), Cyrolife Inc. (US), Zimmer Biomet (US), Kuros Biosciences AG (Switzerland), Orthofix Medical Inc. (US), Smiths & Nephew Plc. (UK) and Among Others
COVID-19 Impact on Global Biosurgery Market:
Owing to the growing incidence of COVID-19, hospitals became high-risk zones, specifically for patients suffering from chronic conditions. As a result, non-critical procedures such as elective surgeries were either canceled or postponed during the first and second quarter of 2020, which resulted in a significant decline in the total number of elective surgical procedures performed. As a result, the demand for biosurgery products witnessed a sharp decline in 2020. The second wave of COVID-19 further deprioritized elective surgical procedures. Governments across the globe have also issued limitations and bans on medical procedures and elective surgeries. With the current pandemic scenario, surgical procedures have witnessed a decline and are only expected to increase in the third quarter of 2021 in countries such as the US. Some countries in the EU have resumed surgical interventions, which has increased the demand for biosurgery products in the region.
The study categorizes the biosurgery market based on product, application, end user, and regional and global level:
Global Biosurgery Market, by Product
Bone Graft Substitutes
Demineralized bone matrix
Synthetic Bone Grafts
Bone Morphogenetic Proteins
Other Bone-Graft Substitutes
Soft-tissue attachments
Synthetic meshes
Biological meshes
Allografts
Xenografts
Hemostatic agents
Thrombin-based hemostatic agents
Oxidized regenerated cellulose-based hemostatic agents
Combination hemostatic agents
Surgical sealants and adhesives
Natural/Biological Sealants and Adhesives
Natural/Biological Sealants and Adhesives, By Type
Fibrin Sealants
Collagen-Based Sealants
Gelatin-Based Sealants
Albumin-Based Sealants
Other Natural/Biological Sealants
Natural/Biological Sealants and Adhesives, By Origin
Human Blood-Based Sealants and Adhesives
Animal-Based Sealants and Adhesives
Synthetic and Semi-Synthetic Sealants and Adhesives
Peg Hydrogels
Cyanoacrylate-Based Sealants and Adhesives
Urethane-Based Sealants and Adhesives
Other Synthetic and Semi-Synthetic Sealants and Adhesives
Adhesion Barriers
Synthetic Adhesion Barriers
Hyaluronic Acid-Based Adhesion Barriers
Regenerated Cellulose-Based Adhesion Barriers
Peg-Based Adhesion Barriers
Other Synthetic Adhesion Barriers
Natural Adhesion Barriers
Collagen & Protein Adhesion Barriers
Fibrin-Based Adhesion Barriers
Staple-Line Reinforcement Agents
Global Biosurgery Market, by Application
Orthopedic Surgery
General Surgery
Neurological Surgery
Cardiovascular Surgery
Reconstructive Surgery
Gynecological Surgery
Urological Surgery
Thoracic Surgery
Others
Global Biosurgery Market, by End User
Hospitals
Clinics
Others
PDF Download: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302
Some of the key geographies mentioned in this report include:
North America (U.S and Canada and rest of North America)
Europe (Germany, France, Italy, and Rest of Europe)
Asia Pacific (China, Japan, India, South Korea, and Rest of Asia-Pacific)
LAMEA (Brazil, Turkey, Saudi Arabia, South Africa, and Rest of LAMEA)
Yorumlar